NASDAQ · NAGE
Niagen Bioscience Inc
Healthcare · Biotechnology
$2.07
Down-$0.07 (-3.28%)
Updated Nov 15, 2026, 5:44 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 529.91M
- P/E ratio
- 29.68
- Dividend yield
- 0.00%
- 52-week range
- $2.04 – $5.40
- Volume
- 315.13K
- Avg. volume
- 1.04M
Price performance · NAGE
NAGE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
NAGE closed at $2.07 after 20 trading sessions, down 17.40% for the selected period.
- Last close
- $2.07
- Period change
- -17.40%
- Period low
- $2.07
- Period high
- $2.54
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $2.13 | $2.15 | $2.06 | $2.065 | 315.13K |
| Nov 12, 2026 | $2.10 | $2.14 | $2.065 | $2.135 | 515.24K |
| Nov 11, 2026 | $2.14 | $2.165 | $2.09 | $2.095 | 373.41K |
| Nov 10, 2026 | $2.26 | $2.26 | $2.12 | $2.15 | 468.88K |
| Nov 9, 2026 | $2.10 | $2.29 | $2.07 | $2.28 | 571.1K |
| Nov 6, 2026 | $2.06 | $2.11 | $2.035 | $2.07 | 601.52K |
| Nov 5, 2026 | $2.32 | $2.34 | $2.05 | $2.105 | 1.31M |
| Nov 4, 2026 | $2.41 | $2.59 | $2.40 | $2.52 | 674.21K |
| Nov 3, 2026 | $2.40 | $2.42 | $2.31 | $2.36 | 549.75K |
| Nov 2, 2026 | $2.36 | $2.41 | $2.35 | $2.40 | 557.59K |
| Oct 30, 2026 | $2.49 | $2.49 | $2.32 | $2.33 | 526.36K |
| Oct 29, 2026 | $2.58 | $2.58 | $2.50 | $2.50 | 348.38K |
| Oct 28, 2026 | $2.46 | $2.55 | $2.46 | $2.54 | 363.92K |
| Oct 27, 2026 | $2.46 | $2.515 | $2.425 | $2.50 | 473.48K |
| Oct 26, 2026 | $2.43 | $2.45 | $2.385 | $2.44 | 405.83K |
| Oct 23, 2026 | $2.50 | $2.50 | $2.42 | $2.43 | 543.77K |
| Oct 22, 2026 | $2.46 | $2.525 | $2.46 | $2.52 | 502.4K |
| Oct 21, 2026 | $2.52 | $2.52 | $2.425 | $2.47 | 652.26K |
| Oct 20, 2026 | $2.50 | $2.535 | $2.48 | $2.51 | 518.62K |
| Oct 19, 2026 | $2.49 | $2.52 | $2.435 | $2.50 | 508.79K |
Latest NAGE news
The latest Smart Investors Daily articles mentioning NAGE.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

